Skip to main content
# Title Research Member Research Year
11 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Dr. Marwa Tammam Ameen Hammam 2023
12 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Shimaa Hassan Shabaan Hassan 2023
13 Tumor Lymphocytic Infiltration as a Prognostic Factor in Gastric Carcinoma Sanaa Saber Abdelraheem Barakat 2023
14 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Dr. Amen Hamdy Zaki Ali 2023
15 CD44 as a prognostic marker in early colorectal cancer: single center experience “South Egypt cancer institute”, Egypt Amany Nasr Ahmed Mohammed Elemary 2023
16 FOXP3 Expression as a Biomarker in Metastatic Colorectal Cancer Treated with Irinotecan-based Therapy Prof. Ashraf Zeidan Abdalla Ahmed 2023
17 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
Dr. Maged Abdelfatah Amine Hassan 2021
18 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Hanaan Ahmed Mohammed Ahmed 2021
19 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Dr. Alia Mohamed Ali Attia 2021
20 Role of Metastatic Colon Cancer Topography in Pathological and Molecular Variability : A Retrospective Study Matta Gerges Mounir Meshreky 2021